139 related articles for article (PubMed ID: 32769897)
1. Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.
Chen C; Xu Y; Huang X; Mao F; Shen S; Xu Y; Sun Q
Medicine (Baltimore); 2020 Aug; 99(32):e21560. PubMed ID: 32769897
[TBL] [Abstract][Full Text] [Related]
2. Survival Outcomes of Patients with Primary Breast Cancer Following Primary Ovarian Cancer.
Zhang W; Zhang W; Lin Z; Wang F; Li M; Zhu L; Yu Y; Gao Y
Med Sci Monit; 2019 May; 25():3869-3879. PubMed ID: 31125329
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
4. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
5. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer.
Jänicke F; Hölscher M; Kuhn W; von Hugo R; Pache L; Siewert JR; Graeff H
Cancer; 1992 Oct; 70(8):2129-36. PubMed ID: 1394042
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 91 cases of hereditary breast and ovarian cancer].
Li N; Wu LY; Zhang R; Zhang X; Liu LY
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):245-7. PubMed ID: 15949430
[TBL] [Abstract][Full Text] [Related]
7. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
8. Recurrence season impacts the survival of epithelial ovarian cancer patients.
Liu XH; Man YN; Wu XZ
Asian Pac J Cancer Prev; 2014; 15(4):1627-32. PubMed ID: 24641379
[TBL] [Abstract][Full Text] [Related]
9. Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?
Kumar S; Srinivasan A; Phillips A; Madhupriya R; Pascoe J; Nevin J; Elattar A; Balega J; Cummins C; Sundar S; Kehoe ST; Singh K
J Obstet Gynaecol; 2020 Aug; 40(6):849-855. PubMed ID: 31933417
[TBL] [Abstract][Full Text] [Related]
10. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.
Oranratanaphan S; Manchana T; Sirisabya N
Asian Pac J Cancer Prev; 2008; 9(3):403-7. PubMed ID: 18990010
[TBL] [Abstract][Full Text] [Related]
12. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
13. Secondary cytoreductive surgery in recurrent epithelial ovarian cancer: A prognostic analysis with 103 cases.
Fan XM; Zhang J; Niu SH; Li KX; Song CZ
Int J Surg; 2017 Feb; 38():61-66. PubMed ID: 28027999
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
15. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
16. Synchronous, bilateral breast cancer: prognostic value and incidence.
Jobsen JJ; van der Palen J; Ong F; Meerwaldt JH
Breast; 2003 Apr; 12(2):83-8. PubMed ID: 14659335
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases.
Chen L; Zhao Q; Lv X
Arch Gynecol Obstet; 2011 May; 283(5):1133-7. PubMed ID: 20585952
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.
Lee J; Park S; Kim S; Kim J; Ryu J; Park HS; Kim SI; Park BW
Yonsei Med J; 2015 Sep; 56(5):1213-20. PubMed ID: 26256962
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study.
Lee SB; Sohn G; Kim J; Chung IY; Lee JW; Kim HJ; Ko BS; Son BH; Ahn SH
Breast Cancer; 2018 Nov; 25(6):639-649. PubMed ID: 29786773
[TBL] [Abstract][Full Text] [Related]
20. Isolated lymph node recurrence in epithelial ovarian cancer: Recurrence with better prognosis?
Delangle R; Rossard L; Cirier J; Delvallée J; Bendifallah S; Touboul C; Collinet P; Coutant C; Akladios C; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Ballester M; Darai E; Body G; Ouldamer L;
Eur J Obstet Gynecol Reprod Biol; 2020 Jun; 249():64-69. PubMed ID: 32381349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
